Publication | Closed Access

Intravitreal Bevacizumab (Avastin) for Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy, Secondary to Punctate Inner Choroidopathy, or of Idiopathic Origin

Ocular DiseaseVitreous BodyOphthalmologyCentral Serous ChorioretinopathyPathologyOcular PathologyMedicinePunctate Inner ChoroidopathyIntravitreal Bevacizumab